Polyposis Syndromes
Moderators: Aparajita Singh & Matthew Kalady

Endoscopic Management of the Foregut in FAP, Gautam Mankaney
Q&A
Surgical Treatment of Polyposis: the (not so) Good, the Bad, and the Ugly, Paul Wise
Q&A

Randall Burt Lecture
Moderator: Maureen Mork

Burt Introduction
Chemoprevention in Polyposis: Past, Present and Future, Patrick Lynch
Q&A

Conquering Clinical Challenges
Moderators: Julie Moskowitz & Colleen Flahive

How We Do It: Precision Medicine for All Cancer Patients,
Heather Hampel & Gregory Idos & Deborah Harwood & Lauren Gima
Q&A
Hereditary Live! and In Person,
Intro & Moderator: Joshua Sommovilla
Panelists: Paul Wise, Jennifer Weiss, Emma Keel
Case 1, Olga Lavryk & Sarah McGee
Case 2, Ajay Bansal

Presidential Plenary III
Moderators: Bryson Katona & Beth Dudley

O-014 - Lynch Syndrome (LS) Patients with Inflammatory Bowel Disease (IBD) Have Significantly Higher Intestinal Neoplasia Risk than LS Patients without IBD, Abigail Braun
O-015 - Adenoma prevalence and incidence in Lynch syndrome do not differ between genes, Joaquin Castillo
O-016 - HLA Type as a possible modulator of cancer risk in Lynch syndrome: first data from the INDICATE Network, Matthias Kloor
O-017 - Exploring stakeholders’ perspectives on implementing universal germline testing for colorectal cancer: Findings from a clinical practice survey, Sanjeevani Arora
O-018 - Outcomes of patients with Lynch syndrome undergoing restorative proctocolectomy with ileal pouch-anal anastomosis, Olga Lavryk
O-019 - Duodenal disease in MUTYH-associated polyposis: updated findings from an international prospective study, Laura E Thomas